Arcturus Therapeutics Holdings Inc. (ARCT)
NASDAQ: ARCT · Real-Time Price · USD
13.01
-0.02 (-0.15%)
Oct 5, 2026, 9:30 AM EDT - Market open
ARCT Market Cap
ARCT has a market cap or net worth of $369.78 million as of October 5, 2026. Its market cap has decreased by -39.64% in one year.
Market Cap
369.78M
Enterprise Value
201.23M
1-Year Change
-39.64%
Ranking
Category
Stock Price
$13.01
ChartMarket Cap Chart
Since May 22, 2013, ARCT's market cap has increased from $103.00M to $369.78M, an increase of 259.01%. That is a compound annual growth rate of 10.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 5, 2026 | 369.78M | 112.28% |
| Dec 31, 2025 | 174.20M | -62.11% |
| Dec 31, 2024 | 459.70M | -45.44% |
| Dec 29, 2023 | 842.60M | 87.54% |
| Dec 30, 2022 | 449.30M | -53.95% |
| Dec 31, 2021 | 975.60M | -8.18% |
| Dec 31, 2020 | 1.06B | 546.29% |
| Dec 31, 2019 | 164.40M | 238.97% |
| Dec 31, 2018 | 48.50M | 54.95% |
| Dec 29, 2017 | 31.30M | -45.94% |
| Dec 30, 2016 | 57.90M | -32.75% |
| Dec 31, 2015 | 86.10M | 69.16% |
| Dec 31, 2014 | 50.90M | -79.27% |
| Dec 31, 2013 | 245.50M | 138.35% |
| May 22, 2013 | 103.00M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Turn Therapeutics | 386.80M |
| Kyverna Therapeutics | 385.28M |
| C4 Therapeutics | 378.92M |
| Prelude Therapeutics | 377.99M |
| Agenus | 372.77M |
| Opus Genetics | 371.05M |
| Enanta Pharmaceuticals | 366.40M |
| Inhibikase Therapeutics | 357.78M |